Hemolytic anemia primary prevention

Hemolytic anemia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hemolytic anemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT Scan
MRI Scan
Echocardiography or Ultrasound
Imaging Findings
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hemolytic anemia primary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hemolytic anemia primary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hemolytic anemia primary prevention
CDC on Hemolytic anemia primary prevention
Hemolytic anemia primary prevention in the news
Blogs on Hemolytic anemia primary prevention
Directions to Hospitals Treating Hemolytic anemia
Risk calculators and risk factors for Hemolytic anemia primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Primary Prevention

Primary prevention for hemolytic anemia includes avoidance of particular triggers for hemolysis. This includes:

• Avoidance of immunotherapeutic drugs
• Avoidance of unnecessary antibiotics like trimethoprim-sulfamethaxone
• Avoidance of fava beans for patients who have G6PD deficiency
• Use of bioprothetic cardiac valves over mechanical valves to prevent valve-induced hemolysis